A new drug shows promise in reducing the symptoms of COPD, one of the top 10 leading cause of death in the U.S., according to the CDC.

A new drug shows promise in reducing the symptoms of COPD, one of the top 10 leading cause of death in the U.S., according to the CDC.

The drug reduced flare-ups in a broader patient population than existing COPD biologics, with U.S. approval expected in early 2027